FDI changes fully compliant with India's WTO commitments: Parkash

Changes made in the FDI norms last year are fully compliant with New Delhi's commitments under WTO, Parliament was informed on Friday

investment, investors, foreign investments, FPI, fdi, emergin markets, funding, tech, economy, gdp, aif, alternative investment fund, capital, startups, tech, savings, money, cash, shares, funds, equity
Illustration by Binay Sinha
Press Trust of India New Delhi
2 min read Last Updated : Feb 12 2021 | 4:59 PM IST

Changes made in the FDI norms last year, which made it mandatory for firms of a country sharing land border with India to seek government nod for all investments, are fully compliant with New Delhi's commitments under WTO, Parliament was informed on Friday.

In a written reply to the Rajya Sabha, Union Minister Som Parkash said in the meetings of the Council for Trade in Services under WTO held in October and November last year, China had raised concern on the changes made in India's Foreign Direct Investment (FDI) policy through Press Note 3 of 2020.

The changes have mandated that an entity of a country, which shares a land border with India or where the beneficial owner of an investment into India is situated in or is a citizen of any such country, can invest only under the government approval route.

"In response, India asserted that FDI from all members of World Trade Organization (WTO), including China, continues to be permitted and the measures are fully compliant with its commitments under WTO," the Minister of State for Commerce and Industry said.

In a separate reply on exports of COVID-19 vaccines, Commerce and Industry Minister Piyush Goyal said vaccines, including COVID-19 vaccines, are covered under a common ITC HS codes - 30022019 (other single vaccine) and 30022029 (other mixed vaccine).

In trade parlance, every product is categorised under a code. It helps in the systematic classification of goods across the globe.

India's export of vaccines, including COVID-19 vaccines, stood at around USD 125.93 million (other single vaccine) and USD 226.74 million (other mixed vaccine) during April-January 2020-21.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Foreign Direct Investment FDIWorld Trade OrganizationParliament

First Published: Feb 12 2021 | 4:57 PM IST

Next Story